Q4 2024 Earnings Call Transcript February 11, 2025 Edwards Lifesciences Corporation beats earnings expectations. Reported EPS is $0.59, expectations were $0.551. Mark Wilterding: [Starts Abruptly] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results